Comparing conventional treatment, single-target rTMS, or dual-target rTMS for the treatment of post-stroke cognitive impairment — clinical effects and neuroscientific insights: study protocol for a randomized controlled trial

DiscussionIf dual-target rTMS in significant improvements in cognitive function, this method could be considered as a first-line clinical treatment for PSCI. This proposed study has the potential to identify a new, evidence-based intervention that can enhance cognition and independent living in patients with cognitive impairment after stroke.Trial registrationChinese Clinical Trial RegistryChiCTR2200066184. It was registered on 26 November 2022.
Source: Trials - Category: Research Source Type: clinical trials